Consumer Insights
Uncover trends and behaviors shaping consumer choices today
Procurement Insights
Optimize your sourcing strategy with key market data
Industry Stats
Stay ahead with the latest trends and market analysis.
Report Overview
2023
Base Year
2018-2023
Historical Year
2024-2032
Forecast Year
Encephalitis Market Analysis
The market growth is driven by significant developments in both pharmaceutical acquisitions and groundbreaking research. For example, Pfizer’s monumental acquisition of Seagen, aimed at diversifying its revenue streams amidst the anticipated decline in COVID-19 product sales and patent expirations, stands as a pivotal move. This acquisition not only provides Pfizer access to Seagen’s lucrative portfolio but also bolsters its already impressive range of approved oncological therapies, potentially influencing the treatment landscape for conditions like autoimmune brain inflammation. This acquisition may further develop a suitable and cutting-edge treatment therapy for better patient outcomes as Seagen is already familiar with the field, bolstering the encephalitis market growth.
Moreover, recent developments in research are further transforming the treatment landscape for autoimmune brain conditions such as encephalitis. For example, the innovative development of specialized CAAR-T cells designed to target and eliminate cells producing harmful antibodies, showcases promising strides in precision medicine. This innovative approach, exhibiting efficacy in preclinical models, signifies a potential development in treating autoimmune brain inflammation, a critical aspect of encephalitis. Such innovative developments are further expected to increase the encephalitis market demand.
Additionally, the emergence of a potential therapeutic agent for autoimmune encephalitis resulting from translational research is further expected to drive the market demand as it will result in more research for the treatment of the condition. This discovery brings hope for a targeted treatment option that could significantly impact the market.
Encephalitis Market Report Snapshots
*While we strive to always give you current and accurate information, the numbers depicted on the website are indicative and may differ from the actual numbers in the main report. At Expert Market Research, we aim to bring you the latest insights and trends in the market. Using our analyses and forecasts, stakeholders can understand the market dynamics, navigate challenges, and capitalize on opportunities to make data-driven strategic decisions.*
Looking for specific insights?
Get in touch with us for a customized solution tailored to your unique requirements and save upto 35%!
Key Questions Answered in the Report
The market attained a value of about USD 20.85 billion in 2023 in the 7 major markets, driven by the rising research and development.
The market is anticipated to grow at a CAGR of 5.04% during the forecast period of 2024-2032 and is likely to reach a market value of USD 32.5 billion by 2032.
The expanding healthcare industry, rising disposable incomes, and the increasing research and development activities are the major factors driving the market growth.
The introduction of a potential therapeutic agent, along with other innovative developments, are the major trends influencing the market growth.
The major regions of the market include United States EU-4 (Germany, France, Italy, Spain) and the United Kingdom, and Japan.
Types of encephalitis can be divided into primary and secondary.
Available treatments include antiviral agents, steroid injections, antibiotics, immunoglobulin therapy, and plasmapheresis, among others.
It can be diagnosed with the help of imaging tests, blood tests, and biopsies, among others.
Dosages could be injections and/or tablets, among others.
Oral and parenteral are the routes of administration in the market.
Distribution channels include hospital pharmacies and retail pharmacies.
Key players involved in the market are Allergan, Merck & Co., Pfizer Inc., GlaxoSmithKline plc,
Melinta LLC, Basilea Pharmaceutica Ltd, Abbott, F. Hoffmann-La Roche Ltd., Mylan N.V., Teva Pharmaceutical Industries Ltd., Cumberland Pharmaceuticals, Fresenius Kabi AG, Lupin, AbbVie Inc., and Endo International plc.
Purchase Full Report
Datasheet
- Selected Sections, One User
- Printing Not Allowed
- Email Delivery in PDF
Free Limited CustomisationPost Sales Analyst Support50% Discount on Next Update
Single User License
One User
- All Sections, One User
- One Print Allowed
- Email Delivery in PDF
Free Limited CustomisationPost Sales Analyst Support50% Discount on Next Update
Five User License
Five Users
- All Sections, Five Users
- Five Prints Allowed
- Email Delivery in PDF
- Free Limited Customisation
- Post Sales Analyst Support
50% Discount on Next Update
Corporate License
Unlimited Users
- All Sections, Unlimited Users
- Unlimited Prints Allowed
- Email Delivery in PDF + Excel
- Free Limited Customisation
- Post Sales Analyst Support
- 50% Discount on Next Update
How To Order
Our step-by-step guide will help you select, purchase, and access your reports swiftly, ensuring you get the information that drives your decisions, right when you need it.
Select License Type
Choose the right license for your needs and access rights.
Click on ‘Buy Now’
Add the report to your cart with one click and proceed to register.
Select Mode of Payment
Choose a payment option for a secure checkout. You will be redirected accordingly.
Strategic Solutions for Informed Decision-Making
Gain insights to stay ahead and seize opportunities.
Get insights & trends for a competitive edge.
Track prices with detailed trend reports.
Analyse trade data for supply chain insights.
Leverage cost reports for smart savings
Enhance supply chain with partnerships.
Connect For More Information
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
We employ meticulous research methods, blending advanced analytics and expert insights to deliver accurate, actionable industry intelligence, staying ahead of competitors.
Our skilled analysts offer unparalleled competitive advantage with detailed insights on current and emerging markets, ensuring your strategic edge.
We offer an in-depth yet simplified presentation of industry insights and analysis to meet your specific requirements effectively.
- Our Insights Store:
-
Industry Statistics
-
Procurement Insights
-
Consumer Insights
Our Offices
Australia
63 Fiona Drive, Tamworth, NSW
+61-448-061-727
India
C130 Sector 2 Noida, Uttar Pradesh 201301
+91-858-608-1494
Philippines
40th Floor, PBCom Tower, 6795 Ayala Avenue Cor V.A Rufino St. Makati City,1226.
+63-287-899-028, +63-967-048-3306
United Kingdom
6 Gardner Place, Becketts Close, Feltham TW14 0BX, Greater London
+44-753-713-2163
United States (Head Office)
30 North Gould Street, Sheridan, WY 82801
+1-415-325-5166
Vietnam
193/26/4 St.no.6, Ward Binh Hung Hoa, Binh Tan District, Ho Chi Minh City
+84-865-399-124
United States (Head Office)
30 North Gould Street, Sheridan, WY 82801
+1-415-325-5166
Australia
63 Fiona Drive, Tamworth, NSW
+61-448-061-727
India
C130 Sector 2 Noida, Uttar Pradesh 201301
+91-858-608-1494
Philippines
40th Floor, PBCom Tower, 6795 Ayala Avenue Cor V.A Rufino St. Makati City, 1226.
+63-287-899-028, +63-967-048-3306
United Kingdom
6 Gardner Place, Becketts Close, Feltham TW14 0BX, Greater London
+44-753-713-2163
Vietnam
193/26/4 St.no.6, Ward Binh Hung Hoa, Binh Tan District, Ho Chi Minh City
+84-865-399-124